Please provide your email address to receive an email when new articles are posted on . A prospective study of community-dwelling older adults demonstrated an independent relationship between silent ...

Some patients with an acute large-vessel ischemic stroke who already show a large-core infarct at early imaging can still benefit from thrombectomy, especially if the procedure successfully restores ...

Bundled cardioprotective medications with simplified delivery reduced the risk of hospitalization for myocardial infarction or stroke among patients at high risk. To assess the effect of promoting a ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Can you have a stroke and not know it? Unfortunately, yes. It is a phenomenon called a silent stroke or, more formally, a silent cerebral infarction. Investigators at the University of Alabama at ...

Background: Rates of death from cardiovascular and cerebrovascular diseases have been steadily declining over the past few decades. Whether such declines are occurring to a similar degree for common ...

Headache is infrequent in acute lacunar infarction, but it might nevertheless have important clinical implications. Arboix et al. investigated whether the site of infarct affects the incidence of ...

Endovascular therapy for acute ischemic stroke is generally avoided when the infarction is large, but the effect of endovascular therapy with medical care as compared with medical care alone for large ...

A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...

Only one-third of 5,600 patients with retinal infarction, or stroke in the eye, underwent basic stroke work-up, and fewer than one in 10 were seen by a neurologist. One in 100 of the retinal ...

Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. At 12 ...